OBJ was founded in 2004 after its directors and founding shareholders spent many years working with magnetic induction systems for bone growth stimulation and connective tissue disorders.
Managing Director and founder Jeffrey Edwards brought together three scientist colleagues – Dr Chris Quirk, Dr Heather Benson and Dr John Snowden – to create the Company’s first magnetic-enhanced drug delivery system known as Dermaportation.
Since then, OBJ has developed a portfolio of more than 20 patents and applications covering the Company’s powered technology, magnetic micro-arrays, enhanced partitioning and penetration technology, and several application and industry specific filings.
OBJ has established multiple commercial relationships with leading companies around the world including a multi-product licensing and development agreement with Procter and Gamble which has seen the release of several consumer products, with many more in development.
The first commercial product to be launched containing OBJ’s magnetic-enhanced delivery technology was the SK-II Eye Wand product, launched in Seoul, South Korea in October 2014. This has since been followed by the SK-II Magnetic Booster and Olay Magnemasks products.